Skip to main content


Pioneering Precision with Dual-System Technology: Reliable CDMO for Smal Molecule APIs and Intermediates

AGC leads the industry with its sophisticated dual-system mill technology, combining the power of opposed bed jet milling and mechanical impact milling in a single integrated solution. This advanced setup, featuring the Hosokawa Alpine Multi-Mill 200 AFG/100 ZPS, enables unprecedented control over particle size reduction, offering manufacturers the flexibility to achieve their exact specifications.

Unmatched Experience Meets Innovation

  • With a 60-year legacy in API manufacturing, AGC brings deep expertise to every micronization project.
  • Our flawless regulatory record, including decades of operations without FDA 483 observations, demonstrates our unwavering commitment to quality and compliance.

State-of-the-Art Equipment

Our investment in Hosokawa Alpine’s cutting-edge technology includes:

  • The 200 AFG Fluidised Bed Opposed Jet Mills: Delivering precise particle size reduction for the finest powder requirements.
  • ZPS Mechanical Impact Mill: Ensuring consistent and controlled particle size distribution across broader ranges.

AGC Dual-System Mill- Micronizer- Hosokawa Alpine Multi-Mill 200 AFG/100 ZPS

AGC’s adoption of a dual-system mill exemplifies its dedication to versatility and flexibility in particle size reduction processes. The integration of opposed bed jet milling and mechanical impact milling allows AGC to

  • Precision particle control from ultra-fine (2µm) to coarse (50µm)
  • Unmatched processing flexibility for diverse pharmaceutical applications
  • Superior particle size distribution homogeneity with global variability as low as 0.00-1.10%
  • Exceptional yield rates of 99.40%, maximizing your valuable API
  • Proven capability to achieve precise D90 < 10μm and D50 between 1.5-2.0μm
  • Complete solution in a single, efficient platform and much more.

This innovative approach ensures exceptional product uniformity and consistency across your entire manufacturing spectrum.

Key Features:

  • Customizable Components
  • Multi-process Modularity
  • Safety-First Engineering
  • Full-scale production environments
  • Design Considerations

Proven Performance Metrics That Drive Value

Our micronization process stands out through three critical success factors that matter most to our clients:

  • Process Efficiency: Our optimized approach minimizes product loss while maximizing throughput, ensuring your valuable materials are handled with utmost care and precision.
  • Particle Size Control: We achieve consistently concentrated particle sizes that meet even the most demanding specifications, helping you maintain strict quality standards for your products.
  • Homogeneity Excellence: Our sophisticated process delivers remarkably uniform results across batches, providing the consistency your pharmaceutical applications demand.

Why Choose AGC for Your Micronization Needs?

  • Dual-system flexibility allowing customized particle size solutions
  • Proven track record in pharmaceutical manufacturing
  • Advanced Hosokawa Alpine technology ensuring superior results
  • Comprehensive particle size control capabilities
  • Exceptional quality standards maintained through every process
  • Reduced Risks and Project Management

Dive deeper into our performance data through our detailed whitepaper, featuring specific metrics that showcase our capabilities and discover how AGC’s cutting-edge micronization technology can enhance your product quality and manufacturing efficiency.

Contact us to learn how our specialized particle size reduction solutions can be tailored to your specific requirements and support your manufacturing goals.

Latest News

AGC PharmaAll of ArticlesCDMO ProcessesThe Key Role of Project Management in a CDMO
11th December 2025

The Key Role of Project Management in a CDMO

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
NoticiasAGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros
25th November 2025

AGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros

AGC Pharma Chemicals inaugurated its new state-of-the-art manufacturing plant in Malgrat de Mar, Barcelona, representing an investment of over 100 million euros. The new facility marks a key milestone in…
NoticiasAGC Pharma Chemicals receives a platinum medal from EcoVadis, placing among the Top 1% in sustainability worldwide
1st November 2025

AGC Pharma Chemicals receives a platinum medal from EcoVadis, placing among the Top 1% in sustainability worldwide

EcoVadis, the global reference in corporate sustainability ratings, has once again recognized our company with the Platinum Medal in Europe site, placing us among the top 1% of the most…